Morgan Stanley upgrades LRCX from Equal Weight to OverweightMorgan Stanley 把 拉姆研究 (LRCX) 评级 上调：Equal Weight → Overweight
The Rating Action
Morgan Stanley upgraded Lam Research Corporation (LRCX) to Overweight from Equal Weight on 2026-05-18. LRCX has a $347.6B market capitalization and closed at $277.96 per share on the announcement date, with a 2.37% intraday price drop prior to the rating release.
Coverage History & Consensus
As of May 1, 2026, the broader analyst consensus for LRCX split across 3 Strong Buy, 25 Buy, 7 Hold, 0 Sell, and 1 Strong Sell ratings, per the provided trend data. Morgan Stanley’s prior Equal Weight placement aligned with the 7 Hold ratings, lagging the 28 total bullish ratings. Today’s upgrade to Overweight shifts the firm’s stance to match the top two consensus tiers, moving from a hold to a buy-equivalent rating. The consensus has remained largely stable over the prior two months, with only minor shifts between Buy and Hold categories.
Cross-Reference to Fundamentals & Insider Activity
This rating change follows two consecutive quarterly earnings beats, per LRCX’s April 22, 2026 8-K filing: for the third quarter of fiscal 2026, the company reported adjusted EPS of $1.47, beating consensus estimates by $0.11, and revenue of $5.84B, surpassing forecasts by $91.1M. Recent insider transactions, documented in SEC Form4 filings, include a May 4, 2026 sale by Senior Vice President Fernandes Neil J, who disposed of 18,170 shares at $255.14 for gross proceeds of $4,635,894, and an April 28, 2026 sale of 6,010 shares by Chief Legal Officer Ava Harter at $258.66 for $1,554,547 alongside multiple exempt stock transfers.
Unsignaled Implications of the Rating Change
This upgrade does not disclose a formal price target, as no target was included in the provided context. It also does not account for the 2.37% intraday price decline LRCX experienced on May 18, 2026, prior to the rating announcement. Finally, the analysis does not reflect institutional position changes reported after December 31, 2025; the latest 13F filing shows 2419 total institutional holders (up 263 year-over-year) with 83% of the float held by institutional investors, with 1,188 positions increased during the fourth quarter of 2025.
The Rating Action
Morgan Stanley upgraded Lam Research Corporation (LRCX) to Overweight from Equal Weight on 2026-05-18. LRCX has a $347.6B market capitalization and closed at $277.96 per share on the announcement date, with a 2.37% intraday price drop prior to the rating release.
Coverage History & Consensus
As of May 1, 2026, the broader analyst consensus for LRCX split across 3 Strong Buy, 25 Buy, 7 Hold, 0 Sell, and 1 Strong Sell ratings, per the provided trend data. Morgan Stanley’s prior Equal Weight placement aligned with the 7 Hold ratings, lagging the 28 total bullish ratings. Today’s upgrade to Overweight shifts the firm’s stance to match the top two consensus tiers, moving from a hold to a buy-equivalent rating. The consensus has remained largely stable over the prior two months, with only minor shifts between Buy and Hold categories.
Cross-Reference to Fundamentals & Insider Activity
This rating change follows two consecutive quarterly earnings beats, per LRCX’s April 22, 2026 8-K filing: for the third quarter of fiscal 2026, the company reported adjusted EPS of $1.47, beating consensus estimates by $0.11, and revenue of $5.84B, surpassing forecasts by $91.1M. Recent insider transactions, documented in SEC Form4 filings, include a May 4, 2026 sale by Senior Vice President Fernandes Neil J, who disposed of 18,170 shares at $255.14 for gross proceeds of $4,635,894, and an April 28, 2026 sale of 6,010 shares by Chief Legal Officer Ava Harter at $258.66 for $1,554,547 alongside multiple exempt stock transfers.
Unsignaled Implications of the Rating Change
This upgrade does not disclose a formal price target, as no target was included in the provided context. It also does not account for the 2.37% intraday price decline LRCX experienced on May 18, 2026, prior to the rating announcement. Finally, the analysis does not reflect institutional position changes reported after December 31, 2025; the latest 13F filing shows 2419 total institutional holders (up 263 year-over-year) with 83% of the float held by institutional investors, with 1,188 positions increased during the fourth quarter of 2025.
This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考，不构成投资建议。